James L. Madara, MD, serves as the CEO and executive vice president of the American Medical Association, the nation’s largest physician organization. He holds the academic title of adjunct professor of pathology at Northwestern University.
Since taking the reins of the AMA in 2011, Dr. Madara has helped sculpt the organization’s visionary long-term strategic plan. As an extension of this vision, he now also serves as chairman of Health2047 Inc., an independent, design-driven innovation firm based in San Francisco whose mission is to help advance the AMA’s goal of improving the health of the nation.
Prior to arriving at the AMA, Dr. Madara spent the first 22 years of his career at Harvard Medical School, receiving both clinical and research training, serving as a tenured professor and as director of the NIH-sponsored Harvard Digestive Diseases Center. Following 5 years as chair of pathology at Emory, Dr. Madara served as dean of the medical school and CEO of the hospitals at the University of Chicago, bringing together the university’s biomedical research, teaching and clinical activities. While there, he oversaw the renewal of the institution’s biomedical campus and engineered significant new affiliations with community hospitals, teaching hospital systems, community clinics and national research organizations.
Dr. Madara also served as senior advisor with Leavitt Partners, an innovative health care consulting and private-equity firm founded by former Secretary of Health and Human Services, Mike Leavitt.
Having published more than 200 original papers and chapters, Dr. Madara has received both national and international awards, and served as editor-in-chief of the American Journal of Pathology and as president of the American Board of Pathology.
In addition to Modern Healthcare consistently naming him as one of the nation’s 50 most influential physician executives, as well as one of the nation’s 100 most influential people in health care, he is a past recipient of a prestigious MERIT Award from the National Institutes of Health. He received the 2011 Davenport Award for lifetime achievement in gastrointestinal disease from the American Physiological Society and the 2011 Mentoring Award for lifetime achievement from the American Gastroenterological Society.
Dr. Madara is an elected member of both the American Society of Clinical Investigation and the Association of American Physicians. He also co-chairs the Value Incentives and Systems Innovation Collaborative of the National Academy of Medicine (NAM), and is a member of NAM’s Leadership Consortium for Value & Science-Driven Health Care.
Dr. Madara and his wife Vicki have 2 children, Max and Alexis.
If technology is to improve health equity, it won’t happen by accident
Strategic planning and purposeful execution is needed to ensure that innovations such as health care AI do not exacerbate bias.
America’s health care crisis is much deeper than COVID-19
The coronavirus pandemic didn’t create the problems in our health system, it revealed them in a way that can no longer be ignored.
Generosity of AMA employees shines during COVID-19 and beyond
AMA employees have a long history of pitching in during times of crisis. Learn how the generosity of the staff has enhanced that legacy during COVID-19.
Physicians are born to care
Despite challenges in practice, physicians are committed to patient care. The AMA is devoted to giving you tools to advance your mission in medicine.
How the new AMA website will help in every stage of your career
The new AMA website is designed to help carry you through your lifelong journey in medicine, from starting out in medical school to improving your skills as a practicing physician.
How physicians and Silicon Valley are working to transform health care
Would it surprise you if I said that the nation’s medical profession and those at the cutting-edge of technological innovation now have a common purpose?